Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as a Distinguished provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Advanced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Advanced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Vitor Pacheco is a Neurologist in Columbia, Maryland. Dr. Pacheco is rated as an Advanced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Tarlov Cysts, Dysarthria, Cervical Myelopathy, and Spinal Tumor.

Dr. Hilary E. Gwynn is an instructor on the medical staff at Kennedy Krieger Institute in the Division of Neurology and Developmental Medicine. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also the site coordinator for the Johns Hopkins pediatric resident developmental disabilities rotation at the Kennedy Krieger Institute. Dr. Gwynn earned her medical degree at the University of Maryland School of Medicine in Baltimore, Maryland in 2000 and completed her pediatrics residency there in 2003. She subsequently joined the Kennedy Krieger Institute in 2003 to attend the fellowship in neurodevelopmental disabilities through the Kennedy Krieger Institute and Johns Hopkins University School of Medicine. Since graduation from the fellowship program in 2007, she has been an active member of the medical staff at Kennedy Krieger Institute. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also a member of the clinical staff of the Department of Pediatrics at Johns Hopkins School of Medicine. Contact for Research Inquiries 801 N. Broadway Baltimore, MD 21205 Phone: (443) 923-3246 Research Summary Dr. Gwynn's clinical and research interests include diagnosis and treatment of the child with developmental disability. She is also investigating medical training methodology as it applies to resident and fellow training in the practice of developmental medicine and child neurology. Dr. Gwynn is rated as an Advanced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Cerebral Palsy, Focal Dystonia, Spastic Diplegia Infantile Type, and Moebius Syndrome.

Dr. Mekonnen is neurologist who specializes in cerebrovascular disease and Neurocritical care. Dr. Mekonnen was born and raised in Addis Ababa, Ethiopia where he attended Saint Joseph High School. Dr. Mekonnen received his medical degree from Jimma University School of Medicine and Master of Science in clinical epidemiology from the Netherland Institute Health Sciences. He completed his adult neurology residency from Howard University Hospital. In addition, Dr. Mekonnen completed a fellowship in vascular neurology at the University of Maryland Medical Center. He was a Fellow in Neurological Critical Care at California Pacific Medical Center from 2012-2013. Following his training, he entered academic career at Howard University. He was neurology clerkship and course director, and program director of the Joint Commission-certified Primary Stroke Care at Howard University Hospital. Since July 2019, Dr. Mekonnen has been practicing stroke and general neurology in DC-Metro area, with admitting privileges at Suburban Hospital and Prince George’s Hospital Center. Dr. Mekonnen is rated as an Advanced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Seizures, Dysarthria, Stroke, Generalized Tonic-Clonic Seizure, and Stent Placement.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is rated as an Experienced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

As the director of the Johns Hopkins Movement Disorders Division, Dr. Kelly Mills cares for patients who have movement disorders such as Parkinson’s disease, atypical parkinsonism, dystonia, ataxia, tremor and Huntington’s disease. He also evaluates and manages patients needing deep brain stimulation to manage their movement symptoms and provides botulinum toxin treatment for various disorders. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might impact cognitive and psychiatric problems. For instance, Dr. Mills studies how deep brain stimulation, when used to treat movement symptoms, can impact cognitive function such as attention, memory or impulsivity. Dr. Mills is a Maryland native and a graduate of the University of Maryland School of Medicine, where he developed an interest in neurology and movement disorders. He trained at the University of California, San Francisco, where he completed his neurology residency as well as a clinical and research fellowship in movement disorders, with a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Movement Disorders, Parkinson's Disease, Essential Tremor, and Drug Induced Dyskinesia.

Lee Akst, M.D., specializes in treating the larynx (voicebox), in particular the treatment of voice and swallowing disorders. He is a leading laryngologist in office-based procedures such as vocal fold injection augmentation, pulsed KTP laser treatment, and laryngeal botox injection. In the operating room, Dr. Akst specializes in phonosurgery for the treatment of vocal cord disease, with emphasis on voice restoration and improvement. A strong focus of his practice involves the use of pulsed angiolytic lasers, which allow for subspecialized care of laryngeal papillomas, laryngeal dysplasia, and early vocal cord cancers while preserving the quality and strength of the voice. Dr. Akst is a national leader in the field of laryngology and serves in leadership roles for the American Laryngological Association, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology-Head and Neck Surgery. He lectures extensively on the treatment of laryngeal disease, teaching other physicians how to care for patients with voice and swallowing concerns. His research interests include the development of robotic laryngeal surgery, the study of voice and swallowing complaints in the elderly, and the advancement of pulsed lasers for the treatment of laryngeal diseases with a focus on leukoplakia. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Akst is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Spasmodic Dysphonia, Laryngitis, Perichondritis, Endoscopy, and Laryngectomy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Dr. Nathan Crone focuses on the diagnosis and treatment of seizures and epilepsy, including the surgical treatment of epilepsy. He is also one of the attending physicians in the Epilepsy monitoring unit. Dr. Crone''s research interests include the real-time mapping of brain function to reduce the possibility of impacting brain function during surgery for epilepsy. He received his medical degree from Louisiana State University School of Medicine. He then completed his residency in neurology at the University of Chicago and fellowships in epilepsy and cognitive neurology at Johns Hopkins. Dr. Crone is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Deep Brain Stimulation.

Dennis Dey is a Neurologist in Cumberland, Maryland. Dr. Dey is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Stroke, Headache, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Transient Ischemic Attack (TIA). Dr. Dey is currently accepting new patients.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

Dr. Jeffrey Rothstein focuses on neuromuscular diseases, with a particular focus on Amyotrophic lateral sclerosis (ALS). Other clinical areas relevant to his laboratory-based research include idiopathic stupor, epilepsy, and motor neuron degeneration. His laboratory includes more than 25 post-doctoral fellows, neurology residents, neuromuscular fellows, junior faculty, undergraduate students, technicians, and ALS clinic staff. He has been the principal and/or local investigator in more than 20 national or international trials in ALS. He is the author of more than 360 articles on basic and clinical neuroscience. Dr. Rothstein's laboratory research is funded through the National Institutes of Health, the Dept of Defense, Target ALS, Maryland TEDCO, Alzheimer's Drug Discovery Foundation, the Muscular Dystrophy Association, the ALS Association, and Answer ALS. Dr. Jeffrey Rothstein received a masters degree in neurochemistry from the University of Chicago and a Ph.D. in physiology and biophysics from the University of Illinois Health Sciences Center. He then obtained his medical degree from the University of Illinois College of Medicine. He went on to complete an internship at the University of North Carolina Memorial Hospital before joining The Johns Hopkins for his residency. While at Johns Hopkins, he became chief resident in neurology and completed his fellowship in neuromuscular disease. He has been Professor of Neurology and Neuroscience at Johns Hopkins for more than 25 years. Dr. Rothstein is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.

Benjamin Fakheri is a primary care provider, practicing in Internal Medicine in Lutherville, Maryland. Dr. Fakheri is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Splenic Infarction.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Experienced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Mohammad Khoshnoodi is a Neurologist in Baltimore, Maryland. Dr. Khoshnoodi is rated as an Experienced provider by MediFind in the treatment of Dysarthria. His top areas of expertise are Peripheral Neuropathy, Chronic Polyradiculoneuritis, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Marina Borodkina, M.D., is a physical medicine and rehabilitation physician who provides acute and post-acute inpatient care at FutureCare skilled nursing centers, as well as at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She is also a wound care specialist. Dr. Borodkina earned her medical degree from St. George’s University School of Medicine in Grenada, West Indies, and completed her residency in physical medicine and rehabilitation at Eastern Virginia Medical School in Norfolk, Virginia. She developed a strong interest in the rehabilitative aspect of medicine early in her training and enjoys practicing her specialty at various acute and post-acute rehabilitation facilities throughout the area. In addition to her medical career, Dr. Borodkina is a classically trained musician. In her free time, she plays the piano and organ frequently for liturgical services and other occasions. Dr. Borodkina is rated as an Experienced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Hemiplegia, Stroke, Necrotizing Myopathy (NM), and Dysarthria.

Sarah Korth, M.D. is an instructor at the Johns Hopkins Department of Physical Medicine and Rehabilitation. She serves as an attending physician at The Johns Hopkins Hospital and the Kennedy Krieger Institute. Dr. Korth’s interests include neuroplasticity of the developing brain, maximizing mobility, spasticity management, neurogenic bowel and bladder management, and a whole-person approach to management of children and adults with congenital conditions, including cerebral palsy and spina bifida. Dr. Korth’s rehabilitation-focused care aims to help people with congenital and acquired disabilities reach their maximum function. Dr. Korth also has an ongoing interest in methods of decreasing health disparities in developing countries. While in medical school, Dr. Korth initiated and developed a sustainable-changes health program called The Paraiso Project in rural Dominican Republic that she actively continues to direct. Dr. Korth is rated as an Experienced provider by MediFind in the treatment of Dysarthria. Her top areas of expertise are Myelomeningocele, Hydrocele, Cerebral Palsy, and Neurogenic Bowel.